| Report Title | Price | Action |
|---|---|---|
| Cells Expressing ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) - Drugs in Development, 2021
Cells Expressing ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) - Drugs in Development, 2021 Summary Cells...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Circadian Rhythm Sleep Disorders (Central Nervous System) - Drugs in Development, 2021
Circadian Rhythm Sleep Disorders (Central Nervous System) - Drugs in Development, 2021 Summary Circadian Rhythm Sleep Disorders (Central Nervous Sys...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Thymidylate Synthase (TYMS or EC 2.1.1.45) - Drugs in Development, 2021
Thymidylate Synthase (TYMS or EC 2.1.1.45) - Drugs in Development, 2021 Summary Thymidylate Synthase (TYMS or EC 2.1.1.45) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| Cells Expressing Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Drugs in Development, 2021
Cells Expressing Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Drugs in Development, 2021 Summary Cells Expressing Insulin...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Hypersomnia (Central Nervous System) - Drugs in Development, 2021
Hypersomnia (Central Nervous System) - Drugs in Development, 2021 Summary Hypersomnia (Central Nervous System) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Thyroid Hormone Receptor Beta (Nuclear Receptor Subfamily 1 Group A Member 2 or c erbA 2 or c erbA Beta or ERBA2 or THRB) - Drugs in Development, 2021
Thyroid Hormone Receptor Beta (Nuclear Receptor Subfamily 1 Group A Member 2 or c erbA 2 or c erbA Beta or ERBA2 or THRB) - Drugs in Development, 2021...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| Cells Expressing Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Drugs in Development, 2021
Cells Expressing Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Drugs in Development, 2021 Summary Cells Expressing Integr...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) (Central Nervous System) - Drugs in Development, 2021
MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) (Central Nervous System) - Drugs in Development, 2021 Summ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| 5-Hydroxytryptamine Receptor 1D (5 HT1D or Serotonin 1D Alpha Receptor or Serotonin Receptor 1D or HTR1D) - Drugs in Development, 2021
5-Hydroxytryptamine Receptor 1D (5 HT1D or Serotonin 1D Alpha Receptor or Serotonin Receptor 1D or HTR1D) - Drugs in Development, 2021 Summary 5-Hyd...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Cells Expressing Neural Cell Adhesion Molecule L1 (CD171 or L1CAM) - Drugs in Development, 2021
Cells Expressing Neural Cell Adhesion Molecule L1 (CD171 or L1CAM) - Drugs in Development, 2021 Summary Cells Expressing Neural Cell Adhesion Molecu...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Opium Withdrawal Syndrome (Central Nervous System) - Drugs in Development, 2021
Opium Withdrawal Syndrome (Central Nervous System) - Drugs in Development, 2021 Summary Opium Withdrawal Syndrome (Central Nervous System) - Drugs i...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Interleukin 12 (IL12) - Drugs in Development, 2021
Interleukin 12 (IL12) - Drugs in Development, 2021 Summary Interleukin 12 (IL12) - Drugs in Development, 2021 provides in depth analysis on Interleu...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Cells Expressing T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021
Cells Expressing T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021 Summary Cells Expressing T Ce...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Panic Disorders (Central Nervous System) - Drugs in Development, 2021
Panic Disorders (Central Nervous System) - Drugs in Development, 2021 Summary Panic Disorders (Central Nervous System) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Nonstructural Protein 5A (NS5A) - Drugs in Development, 2021
Nonstructural Protein 5A (NS5A) - Drugs in Development, 2021 Summary Nonstructural Protein 5A (NS5A) - Drugs in Development, 2021 provides in depth ...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Cells Expressing Tumor Associated Glycoprotein 72 (TAG72) - Drugs in Development, 2021
Cells Expressing Tumor Associated Glycoprotein 72 (TAG72) - Drugs in Development, 2021 Summary Cells Expressing Tumor Associated Glycoprotein 72 (TA...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Gaucher Disease Type III (Genetic Disorders) - Drugs in Development, 2021
Gaucher Disease Type III (Genetic Disorders) - Drugs in Development, 2021 Summary Gaucher Disease Type III (Genetic Disorders) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Oxytocin Receptor (OTR or OXTR) - Drugs in Development, 2021
Oxytocin Receptor (OTR or OXTR) - Drugs in Development, 2021 Summary Oxytocin Receptor (OTR or OXTR) - Drugs in Development, 2021 provides in depth ...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) - Drugs in Development, 2021
Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) - Drugs in Development, 2021 Summary Cruzipain (Major Cysteine Proteinase or Cruzai...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency) (Genetic Disorders) - Drugs in Development, 2021
GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency) (Genetic Disorders) - Drugs in Development, 2021 Summary GM1 Gangliosidosis (Beta Galactosidase...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 |